Concerns about Cyprus weighed the markets down to a lower open with the Dow dropping 78 points to 14,480. Nasdaq fell 20 points to 3232.
On the upside
A Seeking Alpha contributor expects the Food and Drug Administration to approve Chelsea Therapeutics' (Nasdaq: CHTP) symptomatic neurogenic hypotension in Parkinson's disease treatment Northera.
SAIC (NYSE: SAIC) reversed year ago losses to post a profit for the fourth quarter and the company declared a special dividend.
Mad Money's Jim Cramer said that Diana Shipping (NYSE: DSX) was poised to rebound.
On the downside
Morgan Stanley downgraded Cliffs Natural Resources (NYSE: CLF) to an Underweight rating.
Francesca's Holdings (Nasdaq: FRAN) announced a secondary offering of more than 7.39 million common shares.
Aastrom Biosciences (Nasdaq: ASTM) will end development of its critical limb ischemia treatment.
In the broad market, declining issues outpaced advancers by a margin of 3 to 1 on the NYSE and by nearly 4 to 1 on Nasdaq. The broader S&P 500 index lost 8 points to 1555.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here